It is already FDA approved being sold in the US and 12 other countries. Have a look at Carestream website. The product is called DRX-Revolution Mobile X-ray.
Medical technology stocks are hot right now. Show me another one selling below recent capital raising price, with 5x industry demand due to covid-19, with FDA approval, CE Mark, mainstream distributor, price advantage and latest technology with patent. MX1 is stupid cheap and when the market wakes up it will rerate to >$100 million market cap IMO.
